mhurhangee/patent-ind-claim-en huggingface dataset:
A partial ceramic casting mold , comprising: - a first core portion and a first shell portion , the first core portion and the first shell portion both being formed of a photopolymerized material and interfacing with at least a second core portion and a second shell portion , the second core portion and the second shell portion both being formed of a photopolymerized material to form the partial ceramic casting mold ; - a cavity between the first and second core portions and the first and second shell portions , the cavity defining a cast component upon casting, particularly a turbine blade or a stator vane, wherein the first and second core portions and the first and second shell portions are formed of a photopolymerized liquid ceramic photopolymer; wherein the first core portion or the first shell portion includes at least one interlocking feature adapted to interface with an interlocking feature on the second core portion or second shell portion . - a first core portion and a first shell portion , the first core portion and the first shell portion both being formed of a photopolymerized material and interfacing with at least a second core portion and a second shell portion , the second core portion and the second shell portion both being formed of a photopolymerized material to form the partial ceramic casting mold ; - a cavity between the first and second core portions and the first and second shell portions , the cavity defining a cast component upon casting, particularly a turbine blade or a stator vane, wherein the first and second core portions and the first and second shell portions are formed of a photopolymerized liquid ceramic photopolymer; wherein the first core portion or the first shell portion includes at least one interlocking feature adapted to interface with an interlocking feature on the second core portion or second shell portion .
A process for the purification of an antibody fragment from periplasmic cell extract from gram-negative bacteria selected from E. coli strains MC4100, TG1, TG2, DHB4, DH5α, DH1, BL21, K12, XL1Blue, JM109 and W3110 comprising: a) a first chromatography step to capture the antibody fragment wherein a mixture containing an antibody fragment at a concentration of at least 1.5 g/L is subjected to cation exchange chromatography and subsequently eluted to produce a first eluate containing the antibody fragment; and b) a second chromatography step wherein the first eluate is subjected to anion exchange chromatography to capture impurities and produce a flow through containing the antibody fragment, wherein the process comprises not more than two chromatography steps. a) a first chromatography step to capture the antibody fragment wherein a mixture containing an antibody fragment at a concentration of at least 1.5 g/L is subjected to cation exchange chromatography and subsequently eluted to produce a first eluate containing the antibody fragment; and b) a second chromatography step wherein the first eluate is subjected to anion exchange chromatography to capture impurities and produce a flow through containing the antibody fragment,
A method of managing user equipment resource tracking in a visited network using blockchain based smart contracts, the method implemented by a device in a home network of the user equipment, the method comprising: receiving notification from the visited network of the user equipment connection request; installing a smart contract for the user equipment into a blockchain; reporting an identifier for the smart contract to the visited network to enable recording of resource usage of the user equipment to the blockchain and association with the smart contract; and migrating virtual network functions (VNFs) for the user equipment to the visited network. receiving notification from the visited network of the user equipment connection request; installing a smart contract for the user equipment into a blockchain; reporting an identifier for the smart contract to the visited network to enable recording of resource usage of the user equipment to the blockchain and association with the smart contract; and migrating virtual network functions (VNFs) for the user equipment to the visited network.
A method performed by a protection node for protecting a pattern classification node from malicious requests, the method comprising: receiving , from a user node a request containing an original pattern to be classified by a machine learning algorithm performed by the pattern classification node; adding noise to the original pattern to generate a noisy pattern; obtaining a first classification of the noisy pattern based on processing of the noisy pattern by a first clone of the machine learning algorithm performed by the protection node; obtaining a second classification of the original pattern based on forwarding the request for processing of the original pattern by the machine learning algorithm performed by the pattern classification node; comparing the first and second classifications to determine whether the first and second classifications satisfy a defined similarity rule; and using the comparison to manage the request from the user node, wherein managing the request comprises identifying the user node as a distrust user node when the first and second classifications do not satisfy the defined similarity rule. receiving , from a user node a request containing an original pattern to be classified by a machine learning algorithm performed by the pattern classification node; adding noise to the original pattern to generate a noisy pattern; obtaining a first classification of the noisy pattern based on processing of the noisy pattern by a first clone of the machine learning algorithm performed by the protection node; obtaining a second classification of the original pattern based on forwarding the request for processing of the original pattern by the machine learning algorithm performed by the pattern classification node; comparing the first and second classifications to determine whether the first and second classifications satisfy a defined similarity rule; and using the comparison to manage the request from the user node, wherein managing the request comprises identifying the user node as a distrust user node when the first and second classifications do not satisfy the defined similarity rule.
A percutaneous electrical stimulator system comprising: a lead with an electrode percutaneously insertable into a patient, the lead protruding from the patient; a lead connector , fixed to the proximal end of the lead ; a patient cable detachably connected to the lead connector ; a stimulator connected to the patient cable and forming an electrical connection between the stimulator and the electrode to deliver therapeutic stimulation; and wherein the lead , the lead connector , the patient cable , and the stimulator form a series of detachable connections having tension characterised in that : the system in response to a disconnection force that may dislodge the lead from its implanted location is configured to temporarily reduce the tension and/or to detach the patient cable to avoid dislodgement of the lead from its implanted location. a lead with an electrode percutaneously insertable into a patient, the lead protruding from the patient; a lead connector , fixed to the proximal end of the lead ; a patient cable detachably connected to the lead connector ; a stimulator connected to the patient cable and forming an electrical connection between the stimulator and the electrode to deliver therapeutic stimulation; and wherein the lead , the lead connector , the patient cable , and the stimulator form a series of detachable connections having tension characterised in that : the system in response to a disconnection force that may dislodge the lead from its implanted location is configured to temporarily reduce the tension and/or to detach the patient cable to avoid dislodgement of the lead from its implanted location.
A display device comprising: a light source ; an image forming unit configured to receive irradiation light emitted from the light source and emit image light for forming an image; a screen on which the image light forms an image; a housing configured to contain the light source and the image forming unit ; and a holding member configured to hold the screen and attached to the housing ; characterized in that the holding member includes a first holding member configured to hold the screen from a front surface side, and a second holding member configured to hold the screen from a back surface side, and wherein one of the first holding member and the second holding member that has a higher thermal conductivity includes an attachment portion that is attached to the housing . a light source ; an image forming unit configured to receive irradiation light emitted from the light source and emit image light for forming an image; a screen on which the image light forms an image; a housing configured to contain the light source and the image forming unit ; and a holding member configured to hold the screen and attached to the housing ; characterized in that the holding member includes a first holding member configured to hold the screen from a front surface side, and a second holding member configured to hold the screen from a back surface side, and a first holding member configured to hold the screen from a front surface side, and a second holding member configured to hold the screen from a back surface side, and wherein one of the first holding member and the second holding member that has a higher thermal conductivity includes an attachment portion that is attached to the housing .
A method for preparing a compound S P -1, wherein said method comprises the following steps: reacting a compound 61501h with a compound 61501g under alkaline conditions, and then reacting with a compound 61501f to prepare a compound 61502: isolating a compound 61501b by crystallization of the compound 61502: reacting the compound 61501b with a compound 61501c to prepare a compound 61501a: deprotecting the hydroxyl protecting group of the compound 61501a to obtain the compound S P -1: and wherein the purity of the compound S p -1 is not less than 97%. reacting a compound 61501h with a compound 61501g under alkaline conditions, and then reacting with a compound 61501f to prepare a compound 61502: isolating a compound 61501b by crystallization of the compound 61502: reacting the compound 61501b with a compound 61501c to prepare a compound 61501a: deprotecting the hydroxyl protecting group of the compound 61501a to obtain the compound S P -1: and wherein the purity of the compound S p -1 is not less than 97%.
A method of obtaining biodiesel from a vegetable oil, wherein the method includes the following steps: - preparation of mixture of a vegetable oil and methyl formate by keeping it for at least 4 days on 3-4 Å molecular sieves; - heating of the prepared mixture of the vegetable oil and methyl formate up to 25°C while continuously stirring; - performing of chemically catalysed interesterification reaction, at atmospheric pressure and temperature in the range of 28°C to 32°C using catalyst to vegetable oil molar ratio in the range of 0.1-0.15 and reagent to vegetable oil molar ratio in the range of 1:36-1:42 respectively, with a reaction time in the range of 30 to 45 minutes, wherein potassium tert- butoxide solution in tert -butanol or tetrahydrofuran is used as the catalyst and a methyl formate is used as a reagent, - neutralisation of catalyst in the reaction mixture by adding 85% H 3 PO 4 ; - cooling down of reaction mixture to a room temperature; - filtration of sediments from the reaction mixture; - distillation of filtered reaction mixture in the temperature at about 60°C in order to distillate reagent excess; and - settlement of the filtered reaction mixture for at least 2 hours so that separate layers of biodiesel and mixture of formines are formed. - preparation of mixture of a vegetable oil and methyl formate by keeping it for at least 4 days on 3-4 Å molecular sieves; - heating of the prepared mixture of the vegetable oil and methyl formate up to 25°C while continuously stirring; - performing of chemically catalysed interesterification reaction, at atmospheric pressure and temperature in the range of 28°C to 32°C using catalyst to vegetable oil molar ratio in the range of 0.1-0.15 and reagent to vegetable oil molar ratio in the range of 1:36-1:42 respectively, with a reaction time in the range of 30 to 45 minutes, wherein potassium tert- butoxide solution in tert -butanol or tetrahydrofuran is used as the catalyst and a methyl formate is used as a reagent, - neutralisation of catalyst in the reaction mixture by adding 85% H 3 PO 4 ; - cooling down of reaction mixture to a room temperature; - filtration of sediments from the reaction mixture; - distillation of filtered reaction mixture in the temperature at about 60°C in order to distillate reagent excess; and - settlement of the filtered reaction mixture for at least 2 hours so that separate layers of biodiesel and mixture of formines are formed.
A filter device for use in combination with a container, said filter device being adapted to be slidably arranged inside said container for preparing a multi-layered blood product by centrifugation of a liquid comprising components of whole blood, the filter device further comprising a substantially planar mesh for providing a collecting surface for said blood product, and a supporting buoyancy body for lifting the blood product towards the surface of the liquid in the container , wherein the filter device is adapted to be fixed relative to the container , characterised in that the density for said supporting buoyancy body is below the density of blood serum.
A medical device, comprising: a body ; an arm extending from the body and configured to receive a first device such that the first device is suspended relative to the body, wherein translation of the arm relative to the body is configured to move the first device relative to the body; and a receiver extending from the body and configured to receive a second device such that the second device is suspended relative to the body, characterised in that the arm includes an inlet opening and an outlet opening sized and shaped to receive the first device. a body ; an arm extending from the body and configured to receive a first device such that the first device is suspended relative to the body, wherein translation of the arm relative to the body is configured to move the first device relative to the body; and a receiver extending from the body and configured to receive a second device such that the second device is suspended relative to the body, characterised in that the arm includes an inlet opening and an outlet opening sized and shaped to receive the first device.
Agricultural device for spreading a pumpable medium over agricultural land, comprising: - a supporting frame which is configured to be connected to a vehicle ; - at least one first spreader arm which is pivotably connected to the supporting frame and provided with pumpable medium outlets , which first spreader arm is movable between a folded-out position which extends substantially transversely to the direction of travel of the vehicle and laterally from the supporting frame and a transport position which extends substantially in the direction of travel of the vehicle , in the longitudinal direction from the supporting frame ; and - a pumpable medium line which extends from the supporting frame along the spreader arm towards the pumpable medium outlets ; in which the spreader arm comprises at least two portions which are slidable in the longitudinal direction with respect to each other, which spreader arm portions are each provided with medium outlets and which spreader arm portions are displaceable between two positions in which the spreader arm portions more or less overlap one another, characterized in that the medium outlets of the at least two spreader arm portions are rotatable about the longitudinal axis in directions which are turned away from each other. - a supporting frame which is configured to be connected to a vehicle ; - at least one first spreader arm which is pivotably connected to the supporting frame and provided with pumpable medium outlets , which first spreader arm is movable between a folded-out position which extends substantially transversely to the direction of travel of the vehicle and laterally from the supporting frame and a transport position which extends substantially in the direction of travel of the vehicle , in the longitudinal direction from the supporting frame ; and - a pumpable medium line which extends from the supporting frame along the spreader arm towards the pumpable medium outlets ; in which the spreader arm comprises at least two portions which are slidable in the longitudinal direction with respect to each other, which spreader arm portions are each provided with medium outlets and which spreader arm portions are displaceable between two positions in which the spreader arm portions more or less overlap one another, characterized in that the medium outlets of the at least two spreader arm portions are rotatable about the longitudinal axis in directions which are turned away from each other.
A method of forming a medical device for insertion or implantation into a patient, the method comprising: exposing a silicone substrate to plasma in a chamber; and forming a coating on the silicone substrate by plasma-enhanced chemical vapor deposition (PECVD) of a cyclic silicon-containing compound at a chamber pressure of less than about 2.667 Pa (20 mTorr) after exposing the silicone substrate to plasma, the coating comprising at least about 20 atomic weight percent silicon, of which at least 30 atomic weight percent is in a silica oxidation state. exposing a silicone substrate to plasma in a chamber; and forming a coating on the silicone substrate by plasma-enhanced chemical vapor deposition (PECVD) of a cyclic silicon-containing compound at a chamber pressure of less than about 2.667 Pa (20 mTorr) after exposing the silicone substrate to plasma, the coating comprising at least about 20 atomic weight percent silicon, of which at least 30 atomic weight percent is in a silica oxidation state.
A patient support apparatus comprising a controller , a user interface , an air supply , a first patient support zone comprising an air fluidization therapy bed including a fluidization space and a fluidizable medium positioned in the fluidization space, the air fluidization therapy bed receiving a flow of pressurized air from the air supply , the flow of pressurized air operable to fluidize the fluidizable medium, a second patient support zone comprising a plurality of inflatable support bladders , and a first conduit from the air supply to the air fluidization therapy bed , characterised in that the second patient support zone includes a micro-climate assembly coupled to the second zone; in that the micro-climate assembly comprises an upper layer of vapor permeable material, a lower layer coupled to the upper layer to define a chamber having an inlet and an outlet , the chamber having an interior space , a three dimensional material positioned in the interior space , the micro-climate assembly coupled to the air supply to selectively receive a flow of air therefrom, the flow of air entering the chamber through the inlet and exiting the chamber through the outlet ; in that the patient support apparatus further comprises a diverter valve coupled to the first conduit and a second conduit coupled to the diverter valve , the second conduit coupled to the micro-climate assembly , and in that the controller is operable based on user inputs to control the diverter valve to selectively direct a flow of air from the air supply to the micro-climate assembly such that the air supply supplies both the air fluidization therapy bed and the micro-climate assembly .
A method for a control unit for stopping a vehicle when stopping at different types of stop positions , the method comprising the following steps: - (S1) the control unit receiving input about a specific stop position for the vehicle, associated with when the vehicle is about to stop during a stopping sequence, the input being indicative of whether the specific stop position requires a high-precision stop or if a stop with a lower precision can be used; and - (S2) when the stop position requires a high-precision stop, the control unit controlling the stopping sequence such that the vehicle stops with a first stopping precision level with respect to the specific stop position, and when a lower precision can be used for the stop, the control unit controlling the stopping sequence such that the vehicle stops with a second stopping precision level which is lower than the first precision level. - (S1) the control unit receiving input about a specific stop position for the vehicle, associated with when the vehicle is about to stop during a stopping sequence, the input being indicative of whether the specific stop position requires a high-precision stop or if a stop with a lower precision can be used; and - (S2) when the stop position requires a high-precision stop, the control unit controlling the stopping sequence such that the vehicle stops with a first stopping precision level with respect to the specific stop position, and when a lower precision can be used for the stop, the control unit controlling the stopping sequence such that the vehicle stops with a second stopping precision level which is lower than the first precision level.
A portable electrocautery device, comprising - a source of energy, and - an applicator wherein the source of energy is a source of DC energy with the maximal current of 1mA and voltage of 0.8 to 12kV and wherein the applicator further comprises a disposable grounding electrode adapted to conductively connect a patient to the electrocautery device so that an output of a spark discharge between a working electrode and a surface of the skin of the patient is a DC output in the range of 0.3 to 4.0 W. - a source of energy, and - an applicator
A method of evaluating a subject's risk of developing type 2 diabetes, comprising: performing Nuclear Magnetic Resonance measurements of at least one lipoprotein component, at least one branched chain amino acid, and GlycA from an in vitro blood plasma or serum biosample from the subject, wherein GlycA is a composite Nuclear Magnetic Resonance signal from carbohydrate portions of acute phase reactant glycoproteins containing N-acetylglucosamine and/or N-acetylgalactosamine moieties that is detectable at about 2.00 ppm when Nuclear Magnetic Resonance measurements are performed at about 47 degrees C; and performing a computer-implemented calculation of a diabetes risk index for the subject using a mathematical model of risk of developing type 2 diabetes that includes the Nuclear Magnetic Resonance measurements of the at least one lipoprotein component, the at least one branched chain amino acid, and GlycA . performing Nuclear Magnetic Resonance measurements of at least one lipoprotein component, at least one branched chain amino acid, and GlycA from an in vitro blood plasma or serum biosample from the subject, wherein GlycA is a composite Nuclear Magnetic Resonance signal from carbohydrate portions of acute phase reactant glycoproteins containing N-acetylglucosamine and/or N-acetylgalactosamine moieties that is detectable at about 2.00 ppm when Nuclear Magnetic Resonance measurements are performed at about 47 degrees C; and performing a computer-implemented calculation of a diabetes risk index for the subject using a mathematical model of risk of developing type 2 diabetes that includes the Nuclear Magnetic Resonance measurements of the at least one lipoprotein component, the at least one branched chain amino acid, and GlycA .